Close Menu

NEW YORK (GenomeWeb) – Illumina announced after the close of the market on Monday that a UK court has ruled that Ariosa Diagnostics infringed its patent covering a method for noninvasive prenatal testing.

The UK High Court of Justice, Chancery Division, Patents Court issued a judgment finding that Ariosa's Harmony cell-free, DNA-based NIPT infringes Illumina's European patent 1 524 321. The court also found the patent's claims were valid.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.